Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 360° synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising incidence of cancer
3.2.1.2 Growing awareness of nutrition’s role in cancer care
3.2.1.3 Growing geriatric population
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of specialized oncology nutrition products
3.2.2.2 Regulatory challenges
3.3 Growth potential analysis
3.4 Porter’s analysis
3.5 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company positioning matrix
4.4 Strategic dashboard
Chapter 5 Market Estimates and Forecast, By Cancer Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Head and neck cancer
5.3 Stomach and gastrointestinal cancer
5.4 Esophageal cancer
5.5 Liver cancer
5.6 Breast cancer
5.7 Pancreatic cancer
5.8 Lung cancer
5.9 Other cancer types
Chapter 6 Market Estimates and Forecast, By Product Type, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Vitamins and minerals
6.3 Proteins
6.4 Antioxidants
6.5 Other product types
Chapter 7 Market Estimates and Forecast, By Formulation, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Standard
7.3 Elemental
Chapter 8 Market Estimates and Forecast, By Route of Administration, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Oral
8.3 Parenteral
Chapter 9 Market Estimates and Forecast, By Dosage Type, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 Liquid
9.3 Powder
9.4 Other dosage types
Chapter 10 Market Estimates and Forecast, By End-use, 2021 – 2032 ($ Mn)
10.1 Key trends
10.2 Hospitals
10.3 Clinics
10.4 Homecare
10.5 Other end-users
Chapter 11 Market Estimates and Forecast, By Region, 2021– 2032 ($ Mn)
11.1 Key trends
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 France
11.3.4 Spain
11.3.5 Italy
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Australia
11.4.5 Rest of Asia Pacific
11.5 Latin America
11.5.1 Brazil
11.5.2 Mexico
11.5.3 Rest of Latin America
11.6 Middle East and Africa
11.6.1 South Africa
11.6.2 Saudi Arabia
11.6.3 Rest of Middle East and Africa
Chapter 12 Company Profiles
12.1 Abbott Laboratories
12.2 Baxter International Inc.
12.3 B. Braun Melsungen AG
12.4 Danone (Nutricia)
12.5 Fresenius SE & Co. KGaA
12.6 Grifol S.A.
12.7 Hormel Foods Corporation
12.8 Meiji Holdings Co., Ltd.
12.9 Medtrition Inc.
12.10 Nestle S.A.
12.11 Victus, Inc.
